Mr Michael McCormick
Osprey Medical is developing the CINCOR(tm) System for advanced kidney protection during coronary interventions.
The CINCOR System is designed to remove dye (contrast) from the heart before it can enter the kidneys and cause damage known as contrast induced nephropathy (CIN). Dye is routinely used to x-ray the heart during angioplasty and stenting procedures. Patients at high risk of CIN often have pre-existing chronic kidney disease. Prevention of CIN in high risk patients may lead to shorter hospital stays, improved patient outcomes, and may ultimately save patients' lives.